| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 2 |
| 1 | SPIRONOLACTONE | 2 |
| 2 | ALGLUCOSIDASE ALFA | 1 |
| 3 | AMLODIPINE | 1 |
| 4 | CARVEDILOL | 1 |
| 5 | ECULIZUMAB | 1 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL | 1 |
| 7 | HYDROCHLOROTHIAZIDE | 1 |
| 8 | MACITENTAN | 1 |
| 9 | PREDNISONE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORASIDENIB | 1 | 0.0016 |
| 1 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 2 | TOLVAPTAN | 1 | 0.0001 |
| 3 | RIFAXIMIN | 1 | 0.0000 |
| 4 | RISEDRONATE SODIUM | 1 | 0.0000 |
| 5 | ECULIZUMAB | 1 | 0.0000 |
| 6 | MACITENTAN | 1 | 0.0000 |
| 7 | SPIRONOLACTONE | 2 | 0.0000 |
| 8 | LANSOPRAZOLE | 2 | 0.0000 |
| 9 | TADALAFIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 2 | 0.0000 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 8 | Endothelin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 1 | 0.0000 |